In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
North America's top hair restoration surgeons create new medical society with the goal of promoting the highest standards of ethical conduct and responsible patient care.
-- The Medici Drug Delivery System™ is a proprietary subcutaneous delivery system comprised of three unique technologies: osmotic mini-pump technology; mini-pump placement technology; and our high temperature therapeutic stabilization technology
6th Annual BlackLine European User Conference to Feature Speakers from Achmea, Aker Solutions, British Gas, Bureau Veritas, Fiat Chrysler, PepsiCo and Unisys
Salesforce Lightning innovations in Summer '16, the company's 50th product release, spark a developer renaissance and enable anyone to build and customize cloud, social, mobile and intelligent apps with clicks or code
Scott Allen, CMO of FreeWave, expands on core tenets that IoT communications technology must support in the access layer of an IT network - data collection, protection, transmission and control
WDC's Data Center Systems Business Unit to Discuss How Active Data Delivers Value and Accelerates Insights; Company to Demonstrate its Object Storage System for Better Backup and Archiving in the Cloud
Company Announces New Standards-Based Signatures, Hybrid Cloud Deployment Offerings, Three European Data Centers and Trust Service Provider Program, Notes xDTM Developments
-72 week follow up of patients with myelofibrosis, including patients with baseline thrombocytopenia, show pacritinib treatment led to durable reductions in spleen volume and symptom burden-
Results validate urine ctDNA testing as an alternative to tissue and plasma based on a large prospective study of T790M detection and patient response to an EGFR tyrosine kinase inhibitor
This marcus evans meeting will take a look at all aspects of patient centered clinical trials from trial design, operations, the role of the digital age, and patient advocacy groups. In addition, the event will address the challenges and misconceptions of the regulatory environment and explore the economic value of incorporating the patient voice.
DOES16 San Francisco Program Offers Strong Line-up of Speakers from American Airlines, Hearst, Hyatt, Lockheed Martin and Northrop Grumman to Amplify Real-world DevOps Transformation Experiences
"On stage, I play a normal-sized Dreadnought. And in my daily life, especially when touring is in full effect, I play my Martin D Jr. E about 90% of the time. The convenience of it is unmatched and as per usual with Martin guitars, it feels at home in my hands. I am not likely to leave home without it." -Seth Avett, The Avett Brothers
"Jungle-Ready" Technology Provides Wireless Communications for Scalpel At The Cross' EMR Application; Will be Demonstrated at Humanitarian Technology Conference
- Findings from RESONATE™ (PCYC-1112), RESONATE™-2 (PCYC-1115), and HELIOS (CLL3001) studies. This press release corresponds to abstracts #7525 and #7520.
Comparative Analyses with DPP-4 Inhibitors, Including Sitagliptin, and Findings on Use in Weight Management and Type 1 Diabetes Underscore Janssen Commitment to Improving Diabetes Management
First of its kind, two-year, 200-patient NEXT-2 trial utilized Guardant360 testing for therapy selection, and studied clinical response rates across multiple cancer types, including lung, gastric, melanoma, and rare cancers
Game-changing MALDI PharmaPulse (MPP) Solution Enables Mass Spectrometry-based Label-Free Ultra-High Throughput Screening for Primary Screens on Millions of Compounds in Drug Discovery
Unique Trapped Ion Mobility Spectrometry (TIMS) Coupled to Bruker's High-Performance QTOF Mass Spectrometry Enables High-Resolution Compound Separation, Significant Duty Cycle Enhancements and Studies of Protein Conformations, Aggregation and Structural Isomers
Data Reinforces BERG's Commitment to Improving the Standard of Care for Cancer Patients by Combining Biology with Artificial Intelligence for Next-Generation Precision Medicine
Four New Analyses of SEER Registry Provide Additional Evidence that Oncotype DX Accurately Predicts Patient Outcomes in Node-negative and Node-positive Breast Cancer and Reinforce Its Value in Older Women
- Phase 3 data from the MMY3004 (CASTOR) trial to be featured in the Plenary Session at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract #LBA4)
- Secondary objective demonstrated one-year overall survival rate in 32 percent of patients identified with high expression of delta-like protein 3 (DLL3) SCLC
Patient Database Reveals Under-Utilization of Targeted Therapies in Certain Lung Cancer Mutations, Identifies Higher-Risk Stage 1 Breast Cancer Patients Who May Benefit from Adjuvant Chemotherapy